In the wake of the omicron variant and a biotech boom, companies in the pharmaceutical sector’s retail arm are looking to adapt as markets brace for an uncertain year ahead. One of the industry’s most...
网页链接In the wake of the omicron variant and a biotech boom, companies in the pharmaceutical sector’s retail arm are looking to adapt as markets brace for an uncertain year ahead. One of the industry’s most...
网页链接
精彩评论